(2S,3R)-5-Methyl-3-(piperidine-1-carbonyl)-2-(3,4,4-trimethyl-2,5-dioxo-imidazolidin-1-ylmethyl)-hexanoic acid hydroxyamide

ID: ALA305729

PubChem CID: 44313996

Max Phase: Preclinical

Molecular Formula: C20H34N4O5

Molecular Weight: 410.52

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC(C)C[C@@H](C(=O)N1CCCCC1)[C@@H](CN1C(=O)N(C)C(C)(C)C1=O)C(=O)NO

Standard InChI:  InChI=1S/C20H34N4O5/c1-13(2)11-14(17(26)23-9-7-6-8-10-23)15(16(25)21-29)12-24-18(27)20(3,4)22(5)19(24)28/h13-15,29H,6-12H2,1-5H3,(H,21,25)/t14-,15-/m1/s1

Standard InChI Key:  XNKSQYFVFJZMOA-HUUCEWRRSA-N

Molfile:  

     RDKit          2D

 29 30  0  0  1  0  0  0  0  0999 V2000
   -1.9708   -0.7625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7875   -0.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6458   -1.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9625   -1.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2583   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2583    0.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5458    0.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1667    0.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2583   -0.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8875    0.8875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9708    0.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3375   -0.2292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8375   -1.6917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1667   -0.3500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5458    1.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9708    1.7125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6833    0.4750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7208   -1.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1833   -2.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6750   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4833    0.2625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6000    0.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8792    1.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1667    2.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0458    2.9333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8792    2.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6042    2.1208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3125    0.8833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3167    1.7083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6  9  1  1
  7  6  1  0
  8  7  1  0
  9  1  1  0
 10  8  1  0
 11  6  1  0
 12  2  2  0
 13  3  2  0
 14  8  2  0
  7 15  1  1
 16 11  2  0
 17 11  1  0
 18  4  1  0
 19  5  1  0
 20  5  1  0
 21 17  1  0
 22 10  1  0
 23 10  1  0
 24 15  1  0
 25 24  1  0
 26 24  1  0
 27 23  1  0
 28 22  1  0
 29 27  1  0
  4  5  1  0
 29 28  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA305729

   (2S,3R)-N-hydroxy-5-methyl-3-(piperidine-1-carbonyl)-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]hexanamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 410.52

Molecular Weight (Monoisotopic): 410.2529

AlogP: 1.46

#Rotatable Bonds: 7

Polar Surface Area: 110.26

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.85

CX Basic pKa: 0.22

CX LogP: 0.78

CX LogD: 0.77

Aromatic Rings: ┄

Heavy Atoms: 29

QED Weighted: 0.38

Np Likeness Score: -0.38

References

1. Broadhurst M, Brown P, Lawton G, Ballantyne N, Borkakoti N, Bottomley K, Cooper M, Eatherton A, Kilford I, Malsher P, Nixon J, Lewis E, Sutton B, Johnson W.  (1997)  Design and synthesis of the cartilage protective agent (CPA, Ro32-3555),  7  (17): [10.1016/S0960-894X(97)00416-2]

Source

Source(1):

• Scientific Literature